Ensure patient is in a fasted state for 4 hours. Perform a focused physical examination of the target area. Confirm patient allergies and coagulation status. Obtain informed consent. Apply local anesthetic gel or spray to the target site as required.
Observe the patient for 30 minutes for any signs of discomfort or immediate complications. Provide instruction on portable suction device management. Schedule follow-up for dressing change in 48-72 hours. Patient is discharged immediately if stable.
Comprehensive Clinical Guide: Endoscopic Vacuum Therapy (EVAC)
Endoscopic Vacuum Therapy (EVAC), also frequently referred to as Endoscopic Vacuum-Assisted Closure (E-VAC), represents a paradigm shift in the management of complex gastrointestinal (GI) defects, specifically anastomotic leaks, iatrogenic perforations, and postsurgical cavities. By applying controlled negative pressure directly to the site of a defect, EVAC facilitates wound healing, promotes granulation tissue formation, and mitigates the risk of systemic sepsis. This guide serves as an authoritative clinical reference for gastroenterologists, surgeons, and critical care specialists.
1. Technical Specifications and Mechanisms of Action
EVAC operates on the foundational principles of negative pressure wound therapy (NPWT), adapted for the luminal environment of the GI tract. The system utilizes a polyurethane or polyvinyl alcohol foam sponge attached to a nasogastric or rectal drainage tube, connected to a suction device.
The Mechanism of Action
The therapeutic efficacy of EVAC is derived from three primary physiological processes:
- Mechanical Debridement: The continuous negative pressure removes exudate, necrotic debris, and bacterial load from the wound cavity, maintaining a clean environment.
- Angiogenesis and Granulation: The application of sub-atmospheric pressure induces mechanical strain on the surrounding tissue, which stimulates the release of growth factors (e.g., VEGF), promoting rapid granulation tissue formation and wound contraction.
- Cavity Reduction: By drawing the edges of the defect together and preventing the accumulation of fluid, the therapy effectively "collapses" the cavity, sealing the leak from the inside out.
Technical Components
| Component | Specification |
|---|---|
| Sponge Material | Reticulated open-cell polyurethane foam (hydrophobic) |
| Drainage Conduit | Multi-lumen nasogastric/rectal tube (12–16 Fr) |
| Pressure Settings | Typically -75 mmHg to -125 mmHg (continuous) |
| Change Frequency | Every 48 to 72 hours (standard) |
2. Clinical Indications and Usage
EVAC is indicated for defects that are resistant to conservative management or traditional stenting.
Primary Indications
- Esophageal Anastomotic Leaks: Following esophagectomy, often the most common application.
- Rectal Anastomotic Leaks: Specifically low anterior resection (LAR) leaks where pelvic sepsis is a significant risk.
- Iatrogenic Perforations: Post-endoscopic mucosal resection (EMR) or submucosal dissection (ESD) complications.
- Surgical Dehiscence: Post-gastrectomy or duodenal stump leaks.
- Chronic Sinus Tracts: Non-healing post-surgical sinuses that have failed to close with conventional therapy.
Patient Selection Criteria
Ideal candidates for EVAC possess a contained or partially contained leak. If the patient exhibits signs of free perforation with diffuse peritonitis, surgical intervention (laparotomy/laparoscopy) remains the gold standard, although EVAC may be utilized as an adjunct post-operatively.
3. Pre-Operative Preparation and Procedure
Patient Preparation
- Imaging: A CT scan with oral/rectal contrast is mandatory to map the geometry of the cavity and assess the size of the defect.
- Informed Consent: Patients must be counseled on the duration of therapy, the need for serial endoscopies, and the potential for discomfort.
- Sedation: Procedures are typically performed under moderate sedation or monitored anesthesia care (MAC).
The Procedure Steps
- Endoscopic Assessment: The endoscopist confirms the location and dimensions of the defect. Debridement of necrotic tissue is performed using biopsy forceps or a snare.
- Sizing the Sponge: The sponge is trimmed to the size of the cavity. It should be large enough to ensure contact with all walls of the cavity but not so large that it exerts excessive pressure on delicate structures (e.g., the trachea or major vessels).
- Deployment:
- For esophageal leaks: The sponge is guided into the cavity over a guidewire.
- For rectal leaks: The sponge is often placed via a long-reach colonoscope or by pulling the drainage tube through an anal catheter.
- Negative Pressure Initiation: Once the sponge is positioned, the suction is activated. Visual confirmation of the sponge "shrinking" and the tissue pulling into the sponge is essential.
- Fixation: The tube is secured to the nostril (for esophageal) or taped to the perianal skin (for rectal) to prevent migration.
4. Post-Operative Recovery and Monitoring
Recovery is marked by serial endoscopic evaluations.
- Routine Exchanges: The sponge must be removed and replaced every 48–72 hours to prevent tissue ingrowth into the foam, which causes pain and bleeding upon removal.
- Monitoring:
- Clinical: Resolution of fever, normalization of white blood cell count, and improvement in inflammatory markers (CRP).
- Endoscopic: Success is defined by the reduction of the cavity size and the appearance of healthy, pink granulation tissue.
- Nutrition: Enteral nutrition is preferred. If the sponge is in the esophagus, a jejunostomy tube is usually required to bypass the site.
5. Risks, Complications, and Contraindications
While EVAC is minimally invasive, it is not without risk.
Potential Complications
- Hemorrhage: The most feared complication. Erosion into adjacent vessels (e.g., the aorta or major pelvic vessels) can occur, particularly if the defect is adjacent to major vasculature.
- Tissue Ingrowth: If the sponge is left in place too long, granulation tissue grows into the pores, making removal traumatic.
- Sponge Migration: Risk of the sponge dislodging into the GI tract.
- Stricture Formation: Excessive granulation tissue may lead to luminal narrowing post-healing, requiring secondary dilation.
Contraindications
- Uncontained Perforation: Free peritoneal contamination.
- Fistulas to Major Vessels: High risk of fatal hemorrhage.
- Uncontrolled Coagulopathy: Increased bleeding risk during placement and removal.
- Patient Non-compliance: The need for repeated procedures requires a stable patient.
6. Alternative Treatments
| Treatment | Mechanism | Limitations |
|---|---|---|
| Self-Expanding Metal Stents (SEMS) | Mechanical sealing | Migration, tissue ingrowth, reflux |
| Endoscopic Clipping | Mechanical closure | Limited to small, acute defects |
| Endoscopic Suturing | Mechanical closure | Requires specialized equipment and skill |
| Surgical Revision | Radical repair | High morbidity, prolonged recovery |
7. Frequently Asked Questions (FAQ)
1. How long does the average EVAC treatment last?
Most defects require 2 to 6 weeks of therapy, with exchanges occurring every 3 days.
2. Is EVAC painful?
Patients may experience a "fullness" sensation. Most patients tolerate the tube well, though esophageal placement can cause throat discomfort.
3. Can the patient eat while on EVAC?
If the sponge is in the esophagus, oral intake is generally prohibited to prevent clogging the sponge. Nutritional support via jejunostomy is standard.
4. What happens if the sponge is hard to remove?
If tissue ingrowth has occurred, the sponge should be gently irrigated with saline, and sometimes a small amount of suction is reversed to help loosen the interface.
5. How do I know if the leak is closing?
Serial endoscopic visual inspection is the gold standard. A reduction in the "depth" of the cavity and the presence of healthy granulation tissue are signs of healing.
6. What is the success rate of EVAC?
Studies report success rates between 85% and 95% for esophageal and rectal anastomotic leaks.
7. What is the risk of aortic erosion?
This is a rare but catastrophic event. Pre-procedural CT imaging is vital to assess the proximity of the defect to the aorta.
8. Can EVAC be used in the pediatric population?
Yes, but specialized, smaller-diameter equipment is required, and the evidence base is more limited compared to adult populations.
9. What suction pressure should be used?
Standard practice is -75 to -125 mmHg. Lower pressures may be used if the patient experiences significant pain or if the cavity is very close to a fragile structure.
10. Does insurance cover EVAC?
In most jurisdictions, EVAC is considered an established medical procedure for anastomotic leaks and is covered under standard surgical/gastroenterological billing codes.
8. Conclusion
Endoscopic Vacuum Therapy has revolutionized the management of GI defects, providing a bridge to healing that avoids the high morbidity associated with salvage surgery. By adhering to strict procedural protocols—specifically regarding the frequency of exchanges and careful monitoring for vascular erosion—clinicians can achieve high rates of success. As endoscopic technology continues to evolve, the application of EVAC is expected to expand, solidifying its role as a cornerstone of modern minimally invasive surgery.
Disclaimer: This guide is intended for clinical educational purposes and does not replace institutional protocols or professional surgical judgment. Always consult current clinical guidelines and manufacturer instructions for specific device utilization.